Weight loss is the only proven disease-modifying strategy for Idiopathic Intracranial Hypertension (IIH). A 5%–10% reduction in total body weight can lead to significant improvement in papilledema, ...
Patients with ‘blinding’ headaches known as Idiopathic Intercranial Hypertension (IIH) could be treated with an injectable peptide used for type 2 diabetes, a new trial has found. The study, published ...
Int Ophthalmol Clin. 2014;54(1):27-41. Much of the data supporting weight loss as treatment for IIH comes from retrospective studies or class III evidence. There has been a long-standing need for ...
Three neuro-ophthalmologists at the John A. Moran Eye Center, University of Utah, participated in a recent NIH-funded study that revealed the use of an inexpensive glaucoma drug (acetazolamide), when ...
Abdullah, E.M. (2026) Intracranial Hypertension as an Initial Presentation of Polycythemia Vera: A Case Report. Open Journal ...
The study goal was to identify risk factors for progressive visual field loss among participants with idiopathic intracranial hypertension and mild visual loss in the Idiopathic Intracranial ...
Intracranial hypertension (IH), a clinical condition typically seen in the intensive care unit, is caused by increased pressure surrounding the brain. In many situations, the cause of chronic IH is ...
Glaucoma Drug, Plus Only 5-10 Percent Weight Loss Helps Restore Vision Loss to Patients with Idiopathic Intracranial Hypertension (IIH) National Institutes of Health (NIH)-Funded Study Published in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback